Evidence map›Paper›PMID 24226770›Full record

ArticleNature2013

Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.

Yukihiro Furusawa, Yuuki Obata, Shinji Fukuda, Takaho A Endo, Gaku Nakato, Daisuke Takahashi, Yumiko Nakanishi, Chikako Uetake, Keiko Kato, Tamotsu Kato and 20 more

Erratum issued 2 registry-linked trialsAbstract read
PubMed Publisher
In one paragraph

Article in Nature, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 2 registered trials, which are not on this map. Cited by 3,218 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3,218citing papers in PubMed, 3 pooled it
103.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05119010 naterminatednot on this mapstarted 2023, after this paper: background citation

A Pilot Study Evaluating a Ketogenic Diet Concomitant to Nivolumab and Ipilimumab in Patients With Metastatic Renal Cell Carcinoma

TypeinterventionalSponsorGustave Roussy, Cancer Campus, Grand ParisRan2023 to 2024Enrolled3ConditionsMetastatic Renal Cell CarcinomaArmsContinuous ketogenic diet, Discontinuous ketogenic diet, beta-hydroxybutyrate (BHB) supplementation
NCT07626606 recruitingnot on this mapstarted 2026, after this paper: background citation

Temporal and Spatial Immune Profiling of Oral Rotavirus Vaccine Responses in Zambian Adults With Environmental Enteropathy

TypeobservationalSponsorCentre for Infectious Disease Research in ZambiaRan2026 to 2026Enrolled43ConditionsFeasibility Study, Vaccine Immune Response, Rota Virus Gastroenteritis, TranscriptomicsArmsRotarix®,
3 · Its place in the literature

Who cites it

3,218 citing papers in PubMed, 3 syntheses or guidelines pooled it, 5,172 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Gut microbes · 2026
    Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Observational

3,158 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors at 8 institutions in 2 countries.

Yukihiro Furusawa1] RIKEN Center for Integrative Medical Sciences (IMS-RCAI), Kanagawa 230-0045, Japan [2] The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan [3].
Yuuki Obata1] RIKEN Center for Integrative Medical Sciences (IMS-RCAI), Kanagawa 230-0045, Japan [2] The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan [3] Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan [4].
Shinji Fukuda1] RIKEN Center for Integrative Medical Sciences (IMS-RCAI), Kanagawa 230-0045, Japan [2] Institute for Advanced Biosciences, Keio University, Yamagata 997-0052, Japan [3].
Takaho A EndoRIKEN Center for Integrative Medical Sciences (IMS-RCAI), Kanagawa 230-0045, Japan.
Gaku NakatoRIKEN Center for Integrative Medical Sciences (IMS-RCAI), Kanagawa 230-0045, Japan.
Daisuke TakahashiRIKEN Center for Integrative Medical Sciences (IMS-RCAI), Kanagawa 230-0045, Japan.
Yumiko NakanishiInstitute for Advanced Biosciences, Keio University, Yamagata 997-0052, Japan.
Chikako UetakeRIKEN Center for Integrative Medical Sciences (IMS-RCAI), Kanagawa 230-0045, Japan.
Keiko Kato1] RIKEN Center for Integrative Medical Sciences (IMS-RCAI), Kanagawa 230-0045, Japan [2] Graduate School of Medical Life Science, Yokohama City University, Kanagawa 230-0045, Japan.
Tamotsu KatoRIKEN Center for Integrative Medical Sciences (IMS-RCAI), Kanagawa 230-0045, Japan.
Masumi TakahashiRIKEN Center for Integrative Medical Sciences (IMS-RCAI), Kanagawa 230-0045, Japan.
Noriko N FukudaInstitute for Advanced Biosciences, Keio University, Yamagata 997-0052, Japan.
Shinnosuke MurakamiInstitute for Advanced Biosciences, Keio University, Yamagata 997-0052, Japan.
Eiji MiyauchiRIKEN Center for Integrative Medical Sciences (IMS-RCAI), Kanagawa 230-0045, Japan.
Shingo HinoFaculty of Agriculture, Shizuoka University, Shizuoka 422-8529, Japan.
Koji Atarashi1] RIKEN Center for Integrative Medical Sciences (IMS-RCAI), Kanagawa 230-0045, Japan [2] PRESTO, Japan Science and Technology Agency, Saitama 332-0012, Japan.
Satoshi OnawaRIKEN Center for Integrative Medical Sciences (IMS-RCAI), Kanagawa 230-0045, Japan.
Yumiko FujimuraThe Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Trevor LockettPreventative Health National Research Flagship, CSIRO Food and Nutritional Sciences, South Australia 5000, Australia.
Julie M ClarkePreventative Health National Research Flagship, CSIRO Food and Nutritional Sciences, South Australia 5000, Australia.
David L ToppingPreventative Health National Research Flagship, CSIRO Food and Nutritional Sciences, South Australia 5000, Australia.
Masaru TomitaInstitute for Advanced Biosciences, Keio University, Yamagata 997-0052, Japan.
Shohei HoriRIKEN Center for Integrative Medical Sciences (IMS-RCAI), Kanagawa 230-0045, Japan.
Osamu OharaRIKEN Center for Integrative Medical Sciences (IMS-RCAI), Kanagawa 230-0045, Japan.
Tatsuya MoritaFaculty of Agriculture, Shizuoka University, Shizuoka 422-8529, Japan.
Haruhiko Koseki1] RIKEN Center for Integrative Medical Sciences (IMS-RCAI), Kanagawa 230-0045, Japan [2] Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan [3] Graduate School of Medical Life Science, Yokohama City University, Kanagawa 230-0045, Japan.
Jun Kikuchi1] Graduate School of Medical Life Science, Yokohama City University, Kanagawa 230-0045, Japan [2] RIKEN Center for Sustainable Resource Science, Kanagawa 230-0045, Japan.
Kenya Honda1] RIKEN Center for Integrative Medical Sciences (IMS-RCAI), Kanagawa 230-0045, Japan [2] CREST, Japan Science and Technology Agency, Saitama 332-0012, Japan.
Koji Hase1] RIKEN Center for Integrative Medical Sciences (IMS-RCAI), Kanagawa 230-0045, Japan [2] The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan [3] PRESTO, Japan Science and Technology Agency, Saitama 332-0012, Japan [4].
Hiroshi Ohno1] RIKEN Center for Integrative Medical Sciences (IMS-RCAI), Kanagawa 230-0045, Japan [2] Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan [3] Graduate School of Medical Life Science, Yokohama City University, Kanagawa 230-0045, Japan.
RIKEN Center for Integrative Medical Sciences · JPKeio University · JPCommonwealth Scientific and Industrial Research Organisation · AUChiba University · JPShizuoka University · JPThe University of Tokyo · JPJapan Science and Technology Agency · JPYokohama City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gut commensal microbes shape the mucosal immune system by regulating the differentiation and expansion of several types of T cell. Clostridia, a dominant class of commensal microbe, can induce colonic regulatory T (Treg) cells, which have a central role in the suppression of inflammatory and allergic responses. However, the molecular mechanisms by which commensal microbes induce colonic Treg cells have been unclear. Here we show that a large bowel microbial fermentation product, butyrate, induces the differentiation of colonic Treg cells in mice. A comparative NMR-based metabolome analysis suggests that the luminal concentrations of short-chain fatty acids positively correlates with the number of Treg cells in the colon. Among short-chain fatty acids, butyrate induced the differentiation of Treg cells in vitro and in vivo, and ameliorated the development of colitis induced by adoptive transfer of CD4(+) CD45RB(hi) T cells in Rag1(-/-) mice. Treatment of naive T cells under the Treg-cell-polarizing conditions with butyrate enhanced histone H3 acetylation in the promoter and conserved non-coding sequence regions of the Foxp3 locus, suggesting a possible mechanism for how microbial-derived butyrate regulates the differentiation of Treg cells. Our findings provide new insight into the mechanisms by which host-microbe interactions establish immunological homeostasis in the gut.

Indexed as

Cell DifferentiationFermentationSymbiosisAcetylationAdoptive TransferAnimalsButyratesColitisColonConserved SequenceFemaleForkhead Transcription FactorsGerm-Free LifeHistonesHomeostasisIntestinal MucosaButyratesForkhead Transcription FactorsFoxp3 protein, mouseHistones

Identifiers

PMID24226770
OpenAlexW1999906527

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.